# FDA Inspection 1062847 - LACSA (PTY) LIMITED - July 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/lacsa-pty-limited/34d4f093-bef1-4987-841a-e7cd58ff9b6e
Source feed: FDA_Inspections

> FDA Inspection 1062847 for LACSA (PTY) LIMITED on July 12, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062847
- Company Name: LACSA (PTY) LIMITED
- Inspection Date: 2018-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 907068 - 2014-11-06](https://www.keypedia.com/records/fda_inspections/lacsa-pty-limited/5a3a74c4-dcca-461e-87f8-81302edf003c)
- [FDA Inspection 755654 - 2011-11-17](https://www.keypedia.com/records/fda_inspections/lacsa-pty-limited/abb6f4de-b0b6-4346-9a30-f41131f2d8a4)

Company: https://www.keypedia.com/companies/lacsa-pty-limited/4eb83b8e-d818-44af-aeb0-c8994881b0ed

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c